The objective of the study was to determine the cost implications of patterns of treatment for
patients with external genital warts. A retrospective case note review was carried out at six …

Background: A vaccine has recently been licensed in many countries that protects against
the human papillomavirus types 6, 11, 16, and 18. Types 6 and 11 account for approximately …

We estimated the prevalence of and costs associated with genital warts among privately
insured individuals from the perspective of a private health plan in the United States. Health …

[Anogenital warts incidence, medical management and costs in women consulting
gynaecologists in France]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Background This study estimated genital warts prevalence, genital-warts-related healthcare
resource use and costs, and self-reported human-papillomavirus-related psychosocial …

Objective: Genital warts are caused by human papillomavirus (HPV), principally types 6 and
11, and are highly contagious. This study assessed treatment patterns and costs of …

Condylomata Acuminata (Genital Warts): Patient Demographics... : Sexually Transmitted
Diseases Condylomata Acuminata (Genital Warts): Patient Demographics and Treating …

Objective To summarize and determine the appropriate use for the new and old
management tools for genital warts. Sources of information The following databases were …

BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …